Population diversity and the performance of warfarin dosing algorithms

Br J Clin Pharmacol. 2011 Sep;72(3):451-3. doi: 10.1111/j.1365-2125.2011.04018.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anticoagulants / administration & dosage*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Cytochrome P-450 CYP2C9
  • Cytochrome P-450 Enzyme System / genetics*
  • Cytochrome P450 Family 4
  • Female
  • Humans
  • Male
  • Mixed Function Oxygenases / genetics*
  • Polymorphism, Single Nucleotide*
  • Vitamin K Epoxide Reductases
  • Warfarin / administration & dosage*
  • White People / genetics*

Substances

  • Anticoagulants
  • Warfarin
  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • Cytochrome P450 Family 4
  • CYP4F2 protein, human
  • Vitamin K Epoxide Reductases